⌘K

Login Start Free

Home/Filings/4/0001140361-25-042854

4//SEC Filing

Wilson Martin 4

Accession 0001140361-25-042854

CIK 0001281895other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:05 PM ET

Size

4.6 KB

Accession

0001140361-25-042854

Insider Transaction Report

Form 4

Period: 2025-11-18

ROCKET PHARMACEUTICALS, INC.RCKT

General Counsel

Transactions

Sale
Common Stock
2025-11-18$2.98/sh−1,646$4,910→ 383,816 total

Footnotes (1)

[F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

ROCKET PHARMACEUTICALS, INC.

CIK 0001281895

Entity typeother

Related Parties

1

filerCIK 0001704342

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 4:05 PM ET
Size: 4.6 KB

View on SEC.gov